vaccinia
viru
vacv
larg
doublestrand
dna
viru
complex
cytoplasm
life
cycl
prototyp
member
orthopoxvirida
genu
poxvirida
famili
includ
variola
viru
caus
agent
smallpox
monkeypox
viru
ectromelia
viru
vacv
use
vaccin
success
global
erad
smallpox
centuri
close
relat
attenu
strain
modifi
vaccinia
viru
ankara
mva
frequent
use
recombin
vaccin
vector
varieti
human
anim
diseas
includ
hiv
malaria
tuberculosi
understand
vacv
life
cycl
therefor
import
sinc
provid
base
develop
effici
safe
novel
vaccin
vacv
like
virus
har
cell
enabl
replic
turn
subvert
multipl
crucial
antivir
pathway
includ
cytokin
product
tolllik
receptor
pathway
activ
dsrna
pkr
respons
addit
vacv
suppress
intrins
extrins
proapoptot
pathway
activ
numer
antiapoptot
prosurviv
pathway
includ
pathway
mekerk
pathway
mapk
pathway
mapkjnk
pathway
modul
mani
differ
signal
pathway
prevent
viralinduc
prematur
cell
death
contribut
abil
poxvirus
replic
wide
rang
cell
type
investig
complex
pathogenhost
relationship
rnai
screen
druggabl
host
target
carri
analys
effect
cellular
protein
deplet
vacv
replic
use
multicycl
vacv
infect
assay
monitor
stage
viru
replic
includ
viru
spread
screen
identifi
rang
previous
identifi
hf
also
novel
hf
pathway
influenc
vacv
infect
may
facilit
develop
broadli
effect
antivir
strategi
optimis
poxviralbas
vaccin
vector
schemat
diagram
workflow
use
rnai
screen
shown
figur
sirna
smartpool
sirna
per
gene
dharmacon
dilut
dispens
volum
use
liquid
handler
qiagen
eight
black
plate
corn
store
need
maximum
h
day
transfect
plate
thaw
transfect
reagent
dharmafect
dharmacon
dilut
hank
buffer
salin
solut
hbss
thermofish
ad
well
contain
sirna
use
multidrop
thermofish
give
final
transfect
reagent
concentr
plate
incub
min
room
temperatur
allow
format
transfect
complex
complex
format
lowpassag
hela
cell
ecacc
approxim
confluent
flask
wash
pb
trypsinis
trypsinedta
lonza
dilut
phenol
redfre
antibioticfre
transfect
medium
fc
mm
hepe
lglu
gibco
cell
volum
ad
well
use
multidrop
plate
incub
h
humidifi
incub
infect
infect
media
remov
plate
invers
media
dmem
gl
dglucos
lglu
pyruv
fc
penicillinstreptomycin
media
contain
vacv
strain
wr
egfp
tag
protein
dilut
moi
ad
use
multidrop
plate
incub
h
media
ad
well
plate
invert
remov
media
viru
final
volum
media
ad
plate
return
incub
h
plate
invert
remov
media
buffer
formal
salin
ad
fix
cell
fluoresc
level
measur
use
polarstar
optima
plate
reader
bmg
labtech
data
eight
replic
use
analysi
background
intens
correct
carri
subtract
median
valu
uninfect
well
data
normalis
use
robust
z
score
method
correct
number
cell
well
correct
number
cell
well
carri
estim
linear
correl
coeffici
level
fluoresc
phenotyp
score
number
cell
toxic
score
use
least
squar
optim
coeffici
use
linearli
adjust
phenotyp
score
one
replic
screen
imag
high
content
screen
system
buffer
formal
salin
remov
cell
invert
plate
cell
wash
room
temperatur
pb
permeabilis
min
room
temperatur
dilut
pb
plate
invert
dilut
phalloidin
invitrogen
molecular
probe
dilut
pb
bsa
ad
incub
min
dark
phalloidin
remov
invers
dapi
dilut
pb
ad
left
cell
analys
autom
microscopi
use
opera
high
content
screen
system
perkin
elmer
acapella
high
content
imag
analysi
softwar
identifi
sirna
smartpool
exert
significantli
toxic
effect
number
cell
well
count
convert
zscore
zscore
equival
number
standard
deviat
away
mean
sirna
treatment
reduc
cell
number
two
standard
deviat
popul
mean
zscore
less
remov
analysi
zscore
equival
cell
compar
popul
mean
select
sirna
smartpool
dilut
sirna
buffer
dispens
triplic
plate
corn
dharmafect
dilut
dmem
give
final
concentr
ad
use
multidrop
follow
min
incub
enabl
complex
format
hela
cell
transfect
media
ad
plate
transfer
humidifi
incub
h
medium
remov
cell
rins
pb
lyse
trizol
invitrogen
triplic
well
combin
rna
extract
purelink
tm
rna
mini
kit
life
technolog
mrna
level
determin
either
taqman
qpcr
genespecif
primer
probe
univers
probe
librari
roch
sybr
green
qpcr
use
appropri
onestep
rtqpcr
kit
thermofish
express
level
normalis
housekeep
cellular
gene
hypoxanthin
phosphoribosyltransferas
hprt
calibr
mocktransfect
cell
qpcr
carri
duplic
sampl
normalis
express
level
averag
phenotyp
observ
primari
screen
confirm
subset
candid
gene
deconvolut
sirna
smartpool
four
individu
sirna
target
differ
region
gene
dilut
sirna
buffer
dispens
plate
triplic
transfect
h
later
infect
carri
describ
h
post
infect
fluoresc
measur
use
synergi
ht
plate
reader
biotek
experi
carri
three
time
produc
dataset
three
biolog
replic
contain
three
technic
replic
data
analys
use
mix
model
fit
gene
timepoint
gene
time
interact
first
timepoint
valu
fix
effect
valu
observ
first
timepoint
fit
baselin
covari
order
increas
sensit
analysi
repeat
experi
fit
random
effect
caus
variat
result
repeat
experi
taken
account
test
statist
signific
differ
amount
fluoresc
present
well
treat
sirna
well
treat
nonspecif
sirna
target
gene
test
within
mix
model
use
ttest
group
gene
test
separ
plate
group
analys
use
separ
mix
model
phenotyp
consid
confirm
two
four
sirna
result
pvalu
less
six
well
well
plate
transfect
sirna
smartpool
h
later
infect
describ
h
post
infect
cell
scrape
overli
media
collect
frozen
thaw
three
time
sonic
second
misonix
sonic
result
lysat
titrat
cell
monolay
viru
titr
quantifi
plaqu
form
unit
pfu
per
ml
enrich
analysi
perform
respect
pathway
gobas
gene
set
defin
msigdb
well
respect
gene
set
deriv
protein
complex
curat
corum
pin
databas
specif
gene
sort
base
screen
data
propens
gene
set
toward
pro
antivir
activ
sought
use
ranksum
test
multipl
test
three
gene
express
data
set
use
analys
data
set
microarray
vacv
infect
hela
cell
http
wwwbemdncbinlmnihgovprojectsgeoqueryacccgi
data
set
b
microarray
macrophag
monocyt
fibroblast
data
set
c
rnaseq
base
analysi
gene
express
vacv
infect
hela
cell
comparison
rnai
hit
list
two
hela
cell
base
cellular
express
data
set
differenti
expressionbas
rank
gene
g
obtain
condit
ie
timepoint
data
set
summeris
qvalu
qg
calcul
reflect
unexpectedli
high
rank
use
order
statist
particular
rank
third
therefor
qg
quantifi
unexpectedli
often
g
among
strongli
regul
gene
identifi
hf
influenc
vacv
replic
use
druggabl
genom
small
interf
rna
sirna
librari
dharmacon
highthroughput
screen
librari
target
gene
consid
potenti
candid
therapeut
figur
briefli
smartpool
sirna
mix
sirna
per
gene
target
gene
distribut
plate
reversetransfect
hela
cell
cell
infect
h
posttransfect
low
multipl
infect
moi
vacv
strain
h
thu
allow
multipl
complet
viru
replic
cycl
egfp
fluoresc
quantifi
measur
infect
compar
control
order
determin
effect
individu
gene
deplet
vacv
replic
two
posit
sirna
control
known
downregul
growth
target
egfp
two
neg
control
mock
transfect
rscf
sirna
process
risc
machineri
two
nonspecif
sirna
target
herp
simplex
viru
type
includ
duplic
plate
figur
confirm
measur
virusexpress
fluoresc
reliabl
marker
viral
replic
fluoresc
correl
virustitr
determin
standard
plaqu
assay
rang
timepoint
postinfect
treatment
control
inhibitori
sirna
figur
result
pearson
product
moment
correl
coeffici
confirm
fluoresc
reliabl
determin
viru
replic
entir
druggabl
screen
repeat
four
time
duplic
gener
robust
primari
data
set
eight
replic
pairwis
agreement
compar
level
fluoresc
across
eight
replic
reveal
good
reproduc
median
spearman
coeffici
one
replic
vacvinfect
cell
analys
autom
microscopi
use
opera
high
content
screen
system
acapella
high
content
imag
analysi
softwar
quantifi
number
cell
present
well
total
sirna
pool
total
associ
signific
reduct
cell
number
figur
remov
analysi
list
tabl
file
fluoresc
data
remain
well
primari
screen
normalis
platewis
use
robust
zscore
method
summari
valu
calcul
gene
take
mean
across
replic
valu
convert
zscore
correct
number
cell
well
produc
level
fluoresc
per
cell
sirna
neg
zscore
indic
reduct
vacv
replic
posit
zscore
indic
increas
vacv
replic
figur
two
posit
control
sirna
target
egfp
produc
strongli
neg
zscore
expect
median
level
fluoresc
zscore
close
level
fluoresc
seen
well
transfect
nonspecif
sirna
neg
control
indic
roughli
half
sirna
pool
caus
increas
fluoresc
half
caus
decreas
hit
defin
sirna
pool
gener
zscore
use
criteria
hitlist
hf
total
gener
consist
provir
hf
inhibit
replic
upon
deplet
antivir
hf
increas
replic
upon
deplet
tabl
file
confirm
effect
sirna
smartpool
mrna
level
subset
smartpool
transfect
hela
cell
h
total
rna
extract
subject
quantit
rtpcr
determin
level
mrna
target
gene
gene
test
transcript
level
reduc
indic
major
smartpool
function
expect
tabl
file
confirm
effect
gene
deplet
vacv
replic
subset
hf
chosen
basi
potenti
investig
test
use
four
individu
deconvolut
sirna
smartpool
level
viral
fluoresc
compar
seen
nonspecif
sirna
statist
signific
reduct
increas
fluoresc
p
induc
least
individu
sirna
origin
smartpool
requir
confirm
hit
overal
candid
gene
test
method
success
confirm
tabl
file
level
valid
commensur
similar
rnai
screen
viral
replic
report
confirm
primari
screen
hit
within
deconvolut
dataset
valid
level
put
provir
hf
notabl
higher
antivir
hf
antivir
hit
success
valid
comparison
provir
hit
sirna
pool
effect
primari
screen
one
potenti
reason
lower
valid
rate
antivir
hit
might
dynam
rang
viru
replic
assay
inhibitori
effect
easili
demonstr
normal
replic
condit
virtual
cell
well
becam
infect
h
post
infect
data
shown
suggest
system
reach
near
satur
examin
effect
select
sirna
tradit
viral
growth
curv
test
correl
perturb
fluoresc
primari
screen
hela
cell
transfect
one
sirna
smartpool
upregulatori
control
downregulatori
trip
infect
moi
h
analysi
viru
titr
h
interv
plaqu
assay
found
endpoint
titr
correl
close
zscore
obtain
primari
rnai
screen
figur
valid
robust
primari
screen
notabl
howev
whilst
inhibitori
sirna
decreas
maximum
viru
titr
sirna
treatment
direct
candid
antivir
hf
increas
peak
viru
titr
thu
respons
system
suit
detect
inhibitori
perturb
rel
reduc
sensit
detect
individu
antivir
hf
list
individu
hf
analys
gene
alreadi
known
influenc
vacv
replic
numer
exampl
found
includ
clathrin
protein
involv
golgi
vesicular
traffick
requir
product
envelop
vacv
form
well
multipl
compon
ampk
complex
shown
aid
vacv
entri
addit
signal
pathway
regul
protein
identifi
screen
provir
hit
work
demonstr
promot
rapid
vacv
entri
identif
known
host
factor
vacv
followup
identif
role
vacv
replic
support
reliabl
signific
rnai
screen
dataset
overal
eight
replic
genomewid
rnai
screen
multipl
vacv
replic
cycl
identifi
cellular
gene
consist
hf
posit
support
vacv
replic
hf
antivir
effect
prioritis
investig
potenti
vacv
hf
candid
gene
compar
hit
list
viral
rnai
screen
includ
two
recent
publish
vacv
screen
methodolog
previous
publish
vacv
screen
vari
consider
mercer
et
al
measur
growth
thymidinekinasedefici
vacv
strain
western
reserv
h
infect
therebi
identifi
cellular
protein
involv
initi
stage
viru
replic
exclud
analysi
viral
spread
report
provir
hf
antivir
hf
second
screen
sivan
et
al
use
vacv
strain
ihdj
point
mutat
acceler
releas
progeni
virion
cell
surfac
identifi
gene
influenc
viral
replic
h
infect
thu
measur
entir
replic
cycl
emphasi
viral
spread
report
provir
antivir
hf
overlap
hit
list
report
three
vacv
rnai
studi
mercer
et
al
sivan
et
al
studi
depict
figur
b
hf
common
two
studi
list
tabl
file
number
overlap
hit
two
screen
rang
hf
common
three
vacv
studi
small
number
common
hit
sirna
screen
viru
frequent
find
given
variat
methodolog
three
vacv
screen
includ
viral
strain
infect
time
data
analysi
surpris
howev
comparison
enrich
function
pathway
identifi
three
vacv
screen
reveal
mark
similar
discuss
demonstr
power
compar
screen
approach
identifi
signific
cellular
pathway
involv
viru
replic
genomescal
sirna
screen
carri
mani
virus
vacv
includ
west
nile
viru
wnv
hepat
c
viru
hcv
vesicular
stomat
viru
vsv
borna
diseas
viru
enterovirus
dengu
viru
herp
simplex
viru
influenza
viru
host
factor
common
two
screen
could
repres
broadli
act
cellular
protein
generalis
effect
viral
replic
comparison
vacv
hf
identifi
screen
identifi
viral
screen
found
small
overlap
wnv
vsv
borna
diseas
viru
dengu
viru
whilst
vacv
hf
share
influenza
viru
figur
list
overlap
gene
found
tabl
file
amongst
factor
common
nucleocytoplasm
transport
factor
identifi
provir
hit
vacv
screen
report
well
hiv
influenza
viru
screen
locat
cytoplasm
nuclear
face
central
channel
nuclear
pore
complex
npc
involv
revdepend
rna
export
hiv
infect
shown
play
pro
antivir
function
influenza
viru
infect
somewhat
unexpect
provir
hit
screen
sinc
poxviru
replic
assembl
occur
cytoplasm
howev
two
vacv
rnai
screen
publish
recent
also
identifi
number
nuclear
pore
protein
provir
one
screen
demonstr
knockdown
strongli
inhibit
viral
morphogenesi
number
nuclear
pore
protein
identifi
provir
hf
strongli
suggest
poxvirus
requir
function
nuclear
membran
transport
effici
replic
anoth
hf
affect
vacv
influenza
viru
replic
also
known
activ
mapk
signal
pathway
involv
low
phdepend
entri
influenza
viru
vsv
vacv
also
low
phdepend
entri
mechan
may
similarli
reliant
altern
may
requir
activ
mapk
pathway
promot
cell
surviv
post
infect
contrast
ifitm
interferon
induc
transmembran
protein
identifi
function
genom
screen
mediat
resist
influenza
viru
dengu
viru
west
nile
viru
infect
vitro
vivo
well
marburg
ebola
virus
sarscoronaviru
hiv
protein
prevent
entri
virus
plasma
membran
endosom
lysosom
howev
none
effect
vacv
replic
screen
suggest
vacv
resist
repress
effect
protein
famili
figur
determin
whether
express
hf
identifi
rnai
modul
vacv
rnai
hit
list
compar
previous
publish
transcript
profil
data
set
perform
cell
infect
vacv
three
avail
express
profil
data
set
design
b
c
see
materi
method
sourc
use
differ
cell
viru
isol
time
point
compil
compar
correl
mainli
limit
intradata
set
measur
ie
differ
time
point
cell
line
within
data
set
exampl
agreement
data
set
c
use
hela
cell
test
whether
gener
propens
hf
differenti
express
virusinfect
cell
distribut
rnai
hit
compar
whole
rnai
screen
three
transcript
profil
data
set
signific
tendenc
provir
hf
upregul
antivir
hf
downregul
detect
data
shown
subsequ
express
individu
hf
examin
use
transcript
profil
data
two
helabas
studi
c
reveal
specif
exampl
hf
differenti
express
virusinfect
cell
figur
four
provir
hf
hbegf
adm
significantli
upregul
vacvinfect
hela
cell
q
suggest
vacv
might
promot
express
protein
assist
viral
replic
spread
subunit
transcript
factor
cbf
regul
critic
process
myeloid
lymphat
haematopoiesi
chromosom
transloc
mutat
among
frequent
genom
abnorm
differ
type
leukaemia
furthermor
genomewid
associ
studi
found
genet
polymorph
associ
serolog
respons
vacv
vaccin
dryvax
vaccin
wyeth
laboratori
africanamerican
suggest
polymorph
may
influenc
replic
viral
gene
express
liveattenu
vaccin
vivo
caus
differ
strength
adapt
immun
respons
hypothesi
support
identif
provir
vacv
hf
addit
upregul
provir
hf
opposit
exampl
also
identifi
two
antivir
hf
rbak
significantli
upregul
one
provir
hf
downregul
vacvinfect
cell
lack
correl
function
hf
gene
express
transcript
level
serv
underscor
complex
virushost
interact
highlight
need
followup
studi
assess
role
candid
hf
associ
function
pathway
vacv
replic
overrepresent
analysi
complet
vacv
rnai
data
set
perform
respect
pathway
figur
go
figur
base
gene
set
defin
msigdb
databas
well
curat
protein
complex
defin
corum
pin
databas
figur
translat
strongli
enrich
theme
analys
particularli
complex
poxvirus
known
utilis
host
translat
machineri
product
viral
protein
therefor
enrich
translat
provir
theme
valid
screen
method
cellular
translat
machineri
highlight
viral
rnai
screen
essenti
vsv
hepat
c
viru
interestingli
transcript
initi
gener
rna
polymeras
ii
transcript
factor
activ
identifi
function
analysi
rnai
screen
significantli
overrepres
antivir
gobas
gene
set
figur
sevin
et
al
also
report
interfer
dnadepend
rna
polymeras
ii
pathway
enhanc
vacv
spread
work
identifi
individu
antivir
hf
involv
transcript
maz
inflammatori
respons
transcript
factor
also
known
transcript
factor
inspect
individu
confoc
imag
taken
h
pi
cell
deplet
factor
show
notabl
brighter
accumul
egfplabel
viru
line
posit
zscore
overal
primari
screen
figur
orthopoxviru
infect
result
rapid
shut
cellular
transcript
mark
reduct
amount
host
mrna
present
earli
h
post
infect
effect
believ
result
cessat
host
mrna
synthesi
degrad
cellular
mrna
transcript
viral
protein
involv
shutoff
host
cell
transcript
identifi
although
implic
contrast
viral
translat
depend
host
protein
vacv
encod
transcript
enzym
larg
unaffect
gener
repress
cellular
transcript
therefor
vacvinduc
downregul
host
transcript
prevent
host
cell
transcrib
antivir
proinflammatori
gene
programm
cascad
minim
neg
effect
viral
transcript
whilst
vacv
develop
mechan
shut
host
transcript
data
show
viru
replic
improv
transcript
impair
prior
infect
thu
despit
effort
viru
shut
host
transcript
antivir
effect
pathway
persist
vacv
infect
cell
two
member
septin
protein
famili
septin
msfseptin
identifi
rnai
screen
antivir
hf
figur
msfseptin
copurifi
cell
three
septin
protein
septin
suggest
form
function
complex
therefor
group
pathway
analysi
result
signific
represent
q
figur
consist
deplet
septin
septin
increas
viru
replic
although
stringent
cutoff
use
defin
hit
figur
deconvolut
sirna
target
septin
mrna
confirm
enhanc
viru
replic
although
result
famili
member
variabl
tabl
file
septin
also
identifi
provir
hit
recent
report
vacv
sirna
screen
septin
conserv
gtpbind
protein
act
dynam
scaffold
recruit
protein
involv
actin
microtubul
function
cytokinesi
cell
movement
vesicl
traffick
interestingli
recruit
togeth
autophag
protein
cage
shigella
flexneri
cytosol
infect
cell
restrict
bacteri
dissemin
cage
assembl
link
actin
polymeris
activ
flexneri
suggest
similar
mechan
may
employ
host
cell
cage
vacv
virion
activ
actin
polymeris
earli
late
replic
cycl
thu
invok
antivir
effect
two
group
gene
involv
dna
replic
repair
highlight
pathway
analysi
antivir
properti
figur
complex
pcna
genom
surveil
complex
blm
promot
viru
replic
individu
group
member
downregul
figur
pathway
involv
dna
damag
signal
repair
cellular
process
target
numer
virus
specif
dna
damag
signal
pathway
act
host
defenc
mechan
poxviru
infect
detect
respond
foreign
poxvir
dna
induc
intrins
apoptosi
identif
pcna
gene
set
strongli
antipoxvir
hf
rnai
screen
suggest
part
similar
defenc
mechan
ampactiv
kinas
complex
ampk
key
regul
energi
metabol
activ
reduct
atp
prompt
phosphoryl
mani
target
protein
result
activ
catabol
pathway
inhibit
anabol
pathway
also
link
regul
actin
cytoskeleton
ampk
heterotrim
compris
catalyt
subunit
regulatori
subunit
mammal
subunit
sever
isoform
druggabl
rnai
screen
report
screen
seven
gene
identifi
three
promot
vacv
replic
whose
deplet
led
fewer
dimmer
accumul
cytoplasm
egfp
figur
result
broad
agreement
recent
publish
rnai
screen
cellular
kinas
phosphatas
nonpermiss
drosophila
cell
model
vacv
infect
identifi
seven
hit
includ
three
ampk
subunit
studi
perform
loss
function
analysi
hf
involv
vacv
infect
use
rnai
previous
identifi
host
pathway
protein
complex
aid
vacv
replic
translat
ampk
complex
protein
highlight
rnai
screen
addit
howev
rang
novel
host
pathway
protein
identifi
influenc
vacv
infect
dna
damag
repair
pathway
septin
famili
protein
mani
gene
target
rnai
screen
known
drug
inhibitor
work
yield
list
hf
potenti
target
novel
therapeut
